Challenges in Measuring In Vitro Activity of LNP-mRNA Therapeutics
International Journal of Molecular Sciences · 22.08.2025 · 26 (17) · 8152
DOI: 10.3390/ijms26178152 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.08.2025. Verfasst von Giuditta Guerrini und 5 weiteren Autor:innen. Beteiligte Einrichtung: European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy. Hauptthemen laut MEDLINE: Lipids, Nanoparticles, RNA, Messenger. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JRC Exploratory Research Programme, European Commission’s Joint Research Centre (JRC).
Abstract (Originalsprache)
MRNA-based therapeutics and vaccines represent a rapidly expanding frontier in biomedical innovation, with lipid nanoparticles (LNPs) serving as a clinically validated delivery platform. This study explores critical quality attributes of LNP-mRNA formulations, with a particular focus on in vitro biological activity, a key quality attribute of vaccine activity and batch-to-batch consistency. We discuss the importance of optimizing both LNP components and mRNA structure, highlighting recent advances in formulation strategies. Furthermore, we examine the influence of factors such as cell-line selection, experimental design, storage conditions, and targeted cellular delivery on transduction efficiency. Our findings underscore the need for standardized in vitro assays and process-integrated monitoring to support the scalable development and regulatory assessment of mRNA-based therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- European Commission, Joint Research Centre (JRC), 21027 Ispra, Italy.
ORCID-Profile: Giuditta Guerrini, Diletta Scaccabarozzi, Dora Mehn, Ambra Sarracino, Sabrina Gioria, Luigi Calzolai
Förderung
- JRC Exploratory Research Programme
- European Commission’s Joint Research Centre (JRC)
Zitieren
APA
Guerrini, G., Scaccabarozzi, D., Mehn, D., Sarracino, A., Gioria, S., & Calzolai, L. (2025). Challenges in Measuring In Vitro Activity of LNP-mRNA Therapeutics. International Journal of Molecular Sciences, 26(17), 8152. https://doi.org/10.3390/ijms26178152
Vancouver
Guerrini G, Scaccabarozzi D, Mehn D, Sarracino A, Gioria S, Calzolai L. Challenges in Measuring In Vitro Activity of LNP-mRNA Therapeutics. International Journal of Molecular Sciences. 2025;26(17):8152. doi:10.3390/ijms26178152
BibTeX
@article{Guerrini2025,
author = {Guerrini, Giuditta and Scaccabarozzi, Diletta and Mehn, Dora and Sarracino, Ambra and Gioria, Sabrina and Calzolai, Luigi},
title = {Challenges in Measuring In Vitro Activity of LNP-mRNA Therapeutics},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {17},
pages = {8152},
doi = {10.3390/ijms26178152}
}
EUVIMED